搜索结果：Parkinsons

Parkinsons disease is the second most prevalent neurodegenerative disorder with over ten million active cases worldwide and one million new diagnoses per year. Detecting and subsequently diagnosing the disease is challenging because of symptom heterogeneity with respect to complexity, as well as the type and timing of phenotypic manifestations. Typically, language impairment can present in the prodromal phase and precede motor symptoms suggesting that a linguistic-based approach could serve as a diagnostic method for incipient Parkinsons disease. Additionally, improved linguistic models may enhance other approaches through ensemble techniques. The field of large language models is advancing rapidly, presenting the opportunity to explore the use of these new models for detecting Parkinsons disease and to improve on current linguistic approaches with high-dimensional representations of linguistics. We evaluate the application of state-of-the-art large language models to detect Parkinsons disease automatically from spontaneous speech with up to 73% accuracy.

The early detection of Parkinsons disease remains a critical challenge in clinical neuroscience, with electroencephalography offering a noninvasive and scalable pathway toward population level screening. While machine learning has shown promise in this domain, many reported results suffer from methodological flaws, most notably patient level data leakage, inflating performance estimates and limiting clinical translation. To address these modeling pitfalls, we propose a unified evaluation framework grounded in nested cross validation and incorporating three complementary safeguards: (i) patient level stratification to eliminate subject overlap and ensure unbiased generalization, (ii) multi layered windowing to harmonize heterogeneous EEG recordings while preserving temporal dynamics, and (iii) inner loop channel selection to enable principled feature reduction without information leakage. Applied across three independent datasets with a heterogeneous number of channels, a convolutional neural network trained under this framework achieved 80.6% accuracy and demonstrated state of the art performance under held out population block testing, comparable to other methods in the literature

Accurate and interpretable gait analysis plays a crucial role in the early detection of Parkinsons disease (PD),yet most existing approaches remain limited by single-modality inputs, low robustness, and a lack of clinical transparency. This paper presents an explainable multimodal framework that integrates RGB and Depth (RGB-D) data to recognize Parkinsonian gait patterns under realistic conditions. The proposed system employs dual YOLOv11-based encoders for modality-specific feature extraction, followed by a Multi-Scale Local-Global Extraction (MLGE) module and a Cross-Spatial Neck Fusion mechanism to enhance spatial-temporal representation. This design captures both fine-grained limb motion (e.g., reduced arm swing) and overall gait dynamics (e.g., short stride or turning difficulty), even in challenging scenarios such as low lighting or occlusion caused by clothing. To ensure interpretability, a frozen Large Language Model (LLM) is incorporated to translate fused visual embeddings and structured metadata into clinically meaningful textual explanations. Experimental evaluations on multimodal gait datasets demonstrate that the proposed RGB-D fusion framework achieves higher recogn

Parkinsons disease (PD) is considered one of the most frequent neurological diseases in the world. There is a need to study the early and efficient biomarkers of Parkinsons, such as changes in structural disorders like DNA and chromatin, especially at the subcellular level in the human brain. We used two techniques, Partial wave spectroscopy (PWS) and Inverse Participation Ratio (IPR), to detect the changes in structural disorder in the human brain tissue samples. It was observed from the PWS experiment that there was an increase in structural disorder in Parkinsons disease tissues and cells when compared to normal tissues and cells using mesoscopic light transport theory. Furthermore, the IPR experiment also showed DNA and chromatin structural alterations that have the same trend and support the PWS results. The increase in mass density in the nuclei components, such as DNA and chromatin, can be linked to the aggregation of alpha-synuclein in the substantia nigra of the brain. This protein deposition is considered a significant cause of neuronal death in the brains of PD patients. We also did a histological analysis of brain tissues, which supports our results from dual photonics

Understanding the risk and protective factors associated with Parkinsons disease (PD) is crucial for improving outcomes for patients, individuals at risk, healthcare providers, and healthcare systems. Studying these factors not only enhances our knowledge of the disease but also aids in developing effective prevention, management, and treatment strategies. This paper reviews the key risk and protective factors associated with PD, with a particular focus on the biological mechanisms underlying these factors. Risk factors include genetic mutations, racial predispositions, and environmental exposures, all of which contribute to an increased likelihood of developing PD or accelerating disease progression. Conversely, protective factors such as regular physical exercise, adherence to a Mediterranean diet, and higher urate levels have demonstrated potential to reduce inflammation and support mitochondrial function, thereby mitigating disease risk. However, identifying and validating these factors presents significant challenges. To overcome challenges, we propose several solutions and recommendations. Future research should prioritize the development of standardized biomarkers for early

Parkinsons Disease (PD) is a progressive neurological disorder that primarily affects motor functions and can lead to mild cognitive impairment (MCI) and dementia in its advanced stages. With approximately 10 million people diagnosed globally 1 to 1.8 per 1,000 individuals, according to reports by the Japan Times and the Parkinson Foundation early and accurate diagnosis of PD is crucial for improving patient outcomes. While numerous studies have utilized machine learning (ML) and deep learning (DL) techniques for PD recognition, existing surveys are limited in scope, often focusing on single data modalities and failing to capture the potential of multimodal approaches. To address these gaps, this study presents a comprehensive review of PD recognition systems across diverse data modalities, including Magnetic Resonance Imaging (MRI), gait-based pose analysis, gait sensory data, handwriting analysis, speech test data, Electroencephalography (EEG), and multimodal fusion techniques. Based on over 347 articles from leading scientific databases, this review examines key aspects such as data collection methods, settings, feature representations, and system performance, with a focus on re

Despite the promising performance of state of the art approaches for Parkinsons Disease (PD) detection, these approaches often analyze individual speech segments in isolation, which can lead to suboptimal results. Dysarthric cues that characterize speech impairments from PD patients are expected to be related across segments from different speakers. Isolated segment analysis fails to exploit these inter segment relationships. Additionally, not all speech segments from PD patients exhibit clear dysarthric symptoms, introducing label noise that can negatively affect the performance and generalizability of current approaches. To address these challenges, we propose a novel PD detection framework utilizing Graph Convolutional Networks (GCNs). By representing speech segments as nodes and capturing the similarity between segments through edges, our GCN model facilitates the aggregation of dysarthric cues across the graph, effectively exploiting segment relationships and mitigating the impact of label noise. Experimental results demonstrate theadvantages of the proposed GCN model for PD detection and provide insights into its underlying mechanisms

Parkinsons disease, the fastest growing neurodegenerative disorder globally, has seen a 50 percent increase in cases within just two years. As speech, memory, and motor symptoms worsen over time, early diagnosis is crucial for preserving patients quality of life. While machine-learning-based detection has shown promise, relying on a single feature for classification can be error-prone due to the variability of symptoms between patients. To address this limitation we utilized the mPower database, which includes 150,000 samples across four key biomarkers: voice, gait, tapping, and demographic data. From these measurements, we extracted 64 features and trained a baseline Random Forest model to select the features above the 80th percentile. For classification, we designed a simulatable quantum support vector machine (qSVM) that detects high-dimensional patterns, leveraging recent advancements in quantum machine learning. With a novel, simulatable architecture that can be run on standard hardware rather than resource-intensive quantum computers, our model achieves an accuracy of 90 percent and an AUC of 0.98, surpassing benchmark models. By utilizing an innovative classification framewo

Parkinsons Disease (PD) is a neurodegenerative disorder resulting in motor deficits due to advancing degeneration of dopaminergic neurons. PD patients report experiencing tremor, rigidity, visual impairment, bradykinesia, and several cognitive deficits. Although Electroencephalography (EEG) indicates abnormalities in PD patients, one major challenge is the lack of a consistent, accurate, and systemic biomarker for PD in order to closely monitor the disease with therapeutic treatments and medication. In this study, we collected Electroencephalographic data from 15 PD patients and 16 Healthy Controls (HC). We first preprocessed every EEG signal using several techniques and extracted relevant features using many feature extraction algorithms. Afterwards, we applied several machine learning algorithms to classify PD versus HC. We found the most significant metrics to be achieved by the Random Forest ensemble learning approach, with an accuracy, precision, recall, F1 score, and AUC of 97.5%, 100%, 95%, 0.967, and 0.975, respectively. The results of this study show promise for exposing PD abnormalities using EEG during clinical diagnosis, and automating this process using signal processi

Hypomimia is a condition in the early stages of the progression of Parkinsons disease that limits the movement of facial muscles, restricting the accurate depiction of facial expressions. Also known as facial masking, this condition is an early symptom of Parkinson's disease, a neurodegenerative disorder that affects movement. To date, no specific test exists to diagnose the disease. Instead, doctors rely on the patient medical history and symptoms to confirm the onslaught of the disease, delaying treatment. This study aims to develop a diagnostic tool for Parkinsons disease utilizing the Facial Action Coding System, a comprehensive system describing all facially discernible movement. In addition, this project generates image datasets by simulating faces or action unit sets for both Parkinsons patients and non-affected individuals through coding. Accordingly, the model is trained using supervised learning and neural networks. The model efficiency is compared using Convolutional Neural Network and Vision Transformer models and later tested with a test program by passing a Parkinsons disease-affected image as input. The future goal is to develop a self-determining mobile application

Parkinsons disease, PD, is a chronic condition that affects motor skills and includes symptoms like tremors and rigidity. The current diagnostic procedure uses patient assessments to evaluate symptoms and sometimes a magnetic resonance imaging or MRI scan. However, symptom variations cause inaccurate assessments, and the analysis of MRI scans requires experienced specialists. This research proposes to accurately diagnose PD severity with deep learning by combining symptoms data and MRI data from the Parkinsons Progression Markers Initiative database. A new hybrid model architecture was implemented to fully utilize both forms of clinical data, and models based on only symptoms and only MRI scans were also developed. The symptoms based model integrates a fully connected deep learning neural network, and the MRI scans and hybrid models integrate transfer learning based convolutional neural networks. Instead of performing only binary classification, all models diagnose patients into five severity categories, with stage zero representing healthy patients and stages four and five representing patients with PD. The symptoms only, MRI scans only, and hybrid models achieved accuracies of 0.

Parkinsons disease (PD) is a movement disorder and the second most common neurodengerative disease but despite its relative abundance, there are no clinically accepted neuroimaging biomarkers to make prognostic predictions or differentiate between the similar atypical neurodegenerative diseases Multiple System Atrophy and Progressive Supranuclear Palsy. Abnormal connectivity in circuits including the motor circuit and basal ganglia have been previously shown as early markers of neurodegeneration. Therefore, we postulate the combination patterns of interregional dysconnectivity across the brain can be used to form a patient-specific predictive model of disease state and progression in PD. These models, which employ connectivity calculated from noninvasively measured functional MRI, differentially predict between PD and the atypical lookalikes, predict progression on a disease-specific scale, and predict cognitive decline. Further, we identify the connections most informative for progression and diagnosis. When predicting the one-year progression in the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) and Montreal Cognitive asse

In recent years, applications of data mining methods are become more popular in many fields of medical diagnosis and evaluations. The data mining methods are appropriate tools for discovering and extracting of available knowledge in medical databases. In this study, we divided 11 data mining algorithms into five groups which are applied to a data set of patients clinical variables data with Parkinsons Disease (PD) to study the disease progression. The data set includes 22 properties of 42 people that all of our algorithms are applied to this data set. The Decision Table with 0.9985 correlation coefficients has the best accuracy and Decision Stump with 0.7919 correlation coefficients has the lowest accuracy.